Makrolife Biotech is a German high-end biotechnology company specializing in immunology, in-vitro testing systems, scientific product validation, and regulatory market preparation. For over seven years, Makrolife has been developing innovative solutions at the intersection of active ingredient development, immunology research, and clinical diagnostics.

Originally founded as a research and active ingredient development company, our focus was on the development of clinical-grade compounds, anti-tumoral mechanisms, and the targeted modulation and repolarization of macrophages. This scientific foundation remains at the heart of Makrolife, enabling us to deliver highly precise human-based immune analyses, macrophage polarization tests, cytokine profiling, biocompatibility assessments, and clinically relevant in-vitro evidence for partners worldwide.

Today, Makrolife Biotech is much more than a laboratory:
We operate a complete warehouse, regulatory departments, fulfilment structures, large-scale production capacities, and production-proximate quality management. This allows us to manage the entire development and market entry process – from initial formulations, through comprehensive safety and efficacy testing, IVDR/CE regulatory compliance, clinical performance dossiers, to healthcare marketing, product launch, clinical implementation, and internationalization via our global partner and hospital network.

Makrolife Biotech thus provides a fully integrated end-to-end solution that unites research, validation, production, logistics, and market access on a single platform – for companies aiming to scale quickly, safely, and scientifically in Europe and worldwide.